Back to top
more

AMN Healthcare Services (AMN)

(Delayed Data from NYSE)

$41.01 USD

41.01
1,000,317

-1.41 (-3.32%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $40.94 -0.07 (-0.17%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 31% (173 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why You Should Hold on to Syneos Health (SYNH) for Now

by Zacks Equity Research

Investors about optimistic about Syneos Health (SYNH) given its better-than-expected results as well as strong segmental performance during the third quarter.

Here's Why You Should Add Omnicell (OMCL) To Your Portfolio

by Zacks Equity Research

Investors are optimistic about Omnicell (OMCL) owing to its better-than-expected results in the third quarter and robust segmental performance.

Walgreens (WBA) to Offer COVID-19 Vaccine Booster Shots

by Zacks Equity Research

Individuals aged 18 years or older are eligible to avail Pfizer, Moderna or Johnson & Johnson COVID-19 vaccine boosters from Walgreens' (WBA) stores.

Surging Earnings Estimates Signal Upside for AMN Healthcare (AMN) Stock

by Zacks Equity Research

AMN Healthcare (AMN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks.com featured highlights include: Vista Outdoor, AMN, Standard Motor, and Albertsons Companies

by Zacks Equity Research

Zacks.com featured highlights include: Vista Outdoor, AMN, Standard Motor, and Albertsons Companies

Zacks.com featured highlights include: AutoNation, AMN, Olin, Franchise, and Harley-Davidson

by Zacks Equity Research

Zacks.com featured highlights include: AutoNation, AMN, Olin, Franchise, and Harley-Davidson

Urmimala Biswas headshot

5 Finest PEG Stocks for GARP Investors

by Urmimala Biswas

Stocks that have qualified the screening are AutoNation (AN), AMN Healthcare Services (AMN), Olin Corporation (OLN), Franchise Group (FRG) and Harley-Davidson (HOG).

Nilanjan Banerjee headshot

Combat Market Volatility With These 4 Low-Beta Stocks

by Nilanjan Banerjee

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Vista Outdoor (VSTO), AMN Healthcare (AMN), Standard Motor (SMP) & Albertsons (ACI) are well poised to gain.

AMN vs. GDRX: Which Stock Is the Better Value Option?

by Zacks Equity Research

AMN vs. GDRX: Which Stock Is the Better Value Option?

New Strong Buy Stocks for November 9th

by Zacks Equity Research

AMN, BVH, MRBK, SGH, and TX have been added to the Zacks Rank #1 (Strong Buy) List on November 9th.

AMN Healthcare (AMN) Loses 13.1% Despite Q3 Earnings Beat

by Zacks Equity Research

AMN Healthcare's (AMN) robust Q3 results demonstrate its segmental strength.

Progyny (PGNY) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

AMN Healthcare Services (AMN) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

AMN Healthcare (AMN) delivered earnings and revenue surprises of 29.10% and 12.31%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

AMN Healthcare Services (AMN) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

AMN or GDRX: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

AMN vs. GDRX: Which Stock Is the Better Value Option?

Walgreens (WBA) to Make Additional Investment in VillageMD

by Zacks Equity Research

Walgreens (WBA) announced a $5.2-billion investment in VillageMD to bolster its strategic position in delivering value-based primary care.

Boston Scientific (BSX) Reports Data Backing Eluvia Stent

by Zacks Equity Research

The positive data demonstrated the superiority of Boston Scientific's (BSX) Eluvia stent compared to bare metal stents in treating patients with peripheral artery disease.

Medtronic (MDT) Sees Business Recovery Despite Volume Pressure

by Zacks Equity Research

According to Medtronic (MDT), healthcare systems are better prepared as vaccination rates continue to increase.

Here's Why You Should Retain ResMed (RMD) Stock for Now

by Zacks Equity Research

Investors are optimistic about ResMed (RMD) owing to new product launches in the SDB market and strong sales of mask products.

Here's Why You Should Add DexCom (DXCM) Stock to Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about DexCom (DXCM) owing to its slew of favorable coverage decisions for its G6 CGM System.

Here is Why Growth Investors Should Buy AMN Healthcare (AMN) Now

by Zacks Equity Research

AMN Healthcare (AMN) possesses solid growth attributes, which could help it handily outperform the market.

AMN vs. AMEH: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

AMN vs. AMEH: Which Stock Is the Better Value Option?

Abbott (ABT) Gets FDA Nod for Amplatzer Talisman System

by Zacks Equity Research

The Amplatzer Talisman PFO Occlusion System from Abbott (ABT) is used to treat patients with a patent foramen ovale and are at risk of recurrent ischemic stroke.

AMN Healthcare (AMN) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

AMN Healthcare (AMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.